This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción HE6
Oak Street Health, Inc., together with its subsidiaries, provides healthcare services to the patients in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Oak Street Health, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$35.00 |
| 52 Week High | US$35.60 |
| 52 Week Low | US$13.20 |
| Beta | 2.23 |
| 1 Month Change | -1.13% |
| 3 Month Change | 35.66% |
| 1 Year Change | 100.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.73% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| HE6 | DE Healthcare | Mercado DE | |
|---|---|---|---|
| 7D | -0.6% | 2.2% | 2.5% |
| 1Y | 100.0% | -1.1% | 6.0% |
Rentabilidad vs. Industria: HE6 exceeded the German Healthcare industry which returned -23.7% over the past year.
Rentabilidad vs. Mercado: HE6 exceeded the German Market which returned -6.3% over the past year.
Volatilidad de los precios
| HE6 volatility | |
|---|---|
| HE6 Average Weekly Movement | 10.7% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: HE6's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: HE6's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2012 | 6,000 | Mike Pykosz | www.oakstreethealth.com |
Resumen de fundamentos de Oak Street Health, Inc.
| Estadísticas fundamentales de HE6 | |
|---|---|
| Capitalización bursátil | €8.65b |
| Beneficios(TTM) | -€462.61m |
| Ingresos (TTM) | €1.96b |
4.4x
Ratio precio-ventas (PS)-18.7x
Ratio precio-beneficio (PE)¿Está HE6 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de HE6 | |
|---|---|
| Ingresos | US$2.16b |
| Coste de los ingresos | US$2.08b |
| Beneficio bruto | US$78.10m |
| Otros gastos | US$587.30m |
| Beneficios | -US$509.20m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -2.08 |
| Margen bruto | 3.61% |
| Margen de beneficio neto | -23.56% |
| Ratio deuda/patrimonio | -366.1% |
¿Cómo se ha desempeñado HE6 a largo plazo?
Ver rendimiento histórico y comparativa